Project

A Phase 2, randomized, non-comparative, two-arm open label, multiple-center study of CP-751,871 in combination with Docetaxel/Prednisone in chemotherapy-naive (Arm A) and Docetaxel/Prednisone refractory (Arm B) patients with hormone insensitive prostate cancer

Completed · 2006 until 2009

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2006
End Date
2009
Study Design
Randomisierte Phase II-Studie
Keywords
Prostatakarzinom
Brief description/objective

Phase II Studie in Patienten mit hormon-refraktärem Prostatakarzinom